Chojnacka M, Diamond B, Ziccheddu B, Rustad E, Maclachlan K, Papadimitriou M, Boyle EM, Blaney P, Usmani S, Morgan G, Landgren O, Maura F(2023) Impact of rare structural variant events in newly diagnosed multiple myeloma Clin Cancer Res(in press) DOI 10.1158/1078-0432.CCR-23-1045, PubMed 37939148
Giannakopoulou E, Lehander M, Virding Culleton S, Yang W, Li Y, Karpanen T, Yoshizato T, Rustad EH, Nielsen MM, Bollineni RC, Tran TT, Delic-Sarac M, Gjerdingen TJ, Douvlataniotis K, Laos M, Ali M, Hillen A, Mazzi S, Chin DWL, Mehta A, Holm JS, Bentzen AK, Bill M, Griffioen M, Gedde-Dahl Tet al.(2023) A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo Nat Cancer, 4(10), 1474-1490 DOI 10.1038/s43018-023-00642-8, PubMed 37783807
Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen KT, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Ostenstad B, Brodtkorb M, Kimby EK, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse Ket al.(2023) Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma Blood Adv(in press) DOI 10.1182/bloodadvances.2023010158, PubMed 37695745